Bioinformatics Market to Reach USD 64.60 Billion by 2034

The global bioinformatics market was valued at USD 20.34 billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2034, reaching USD 64.60 billion. Growth is primarily fueled by advancements in artificial intelligence, genomics, next-generation sequencing, and precision medicine.

According to a new analysis by Maximize Market Research, key drivers for market expansion include the increasing volume of genomic and biological data, the growing adoption of next-generation sequencing, the expansion of precision medicine, and rising research and development activities in the pharmaceutical and biotechnology sectors. Broader applications of computational biology are also supporting the market's growth.

Technological advancements, including artificial intelligence, machine learning, cloud computing, and high-performance computing, are reshaping the bioinformatics landscape. These technologies are enabling faster processing of biological data, enhanced predictive analytics, and scalable genomic research across pharmaceutical, biotechnology, and academic institutions.

Regionally, North America leads the market, supported by advanced pharmaceutical and biotechnology R&D, robust genomics infrastructure, and high adoption of precision medicine and bioinformatics platforms. The Asia Pacific region is identified as the fastest-growing, driven by expanding biotechnology and pharmaceutical industries and increasing investments in precision medicine and cloud-based bioinformatics solutions.